Skip to content

Autoimmune Diabetes Multi Control

by Shenzhen Yhlo Biotech Co., Ltd.

Ref CC829

Autoimmune Diabetes Multi Control (CC829) is an in vitro diagnostic device (EU IVDD general IVD; EU IVDD Class B) made by Shenzhen Yhlo Biotech Co., Ltd., registered in EUDAMED on 1 Mar 2023 (Basic UDI-DI B-CC829RJ), active as of 22 Oct 2026.

Active European Union

CE IVDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-CC829RJ Basic UDI-DI Date1 Mar 2023RegisteredStatusActive

Official records

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/IVDD Active

Specification

EUDAMED

Model / reference
CC829
Primary DI / UDI-DI
D-CC829RJ, 06925912738626
Basic UDI-DI
B-CC829RJ, 692591270126H8
EMDN code
W01021521, W0102152011
Device class
Class IVD General
Class B
EU registration type
Legacy device (under a directive)
Standard device
EU market of registration
Netherlands
Germany

Manufacturer details

EUDAMED SRN
CN-MF-000001137
Authorised representative
Lotus NL B.V. NL-AR-000000121

Similar devices in this category

Other devices filed under CONTROLS FOR AUTOIMMUNITY.

Other devices from Shenzhen Yhlo Biotech Co., Ltd.

See all devices from Shenzhen Yhlo Biotech Co., Ltd. →

Properties

  • Contains human tissues or cells NoEUDAMEDYesEUDAMED
  • Contains animal tissues or cells NoEUDAMEDYesEUDAMED
  • Reagent
  • IVD kit
  • Professional testing
Other properties (8, all answered No)